' 
![]()
SCIENTIFIC SCORE
Moderately Effective
Based on 64 Researches
8
USERS' SCORE
Moderately Good
Based on 79 Reviews
7.8
Supplement Facts
Serving Size: 2 Capsules
Amount Per Serving
%DV
Proprietary Probiotic BlendLacticaseibacillus rhamnosus R0011Lactobacillus helvetius R0052Pediococcus acidilactici R1001Lacticaseibacillus casei R0215Bifidobacterium longum BB536Lactiplantibacillus plantarum R1012Bifidobacterium breve R0070Lactococcus lactis subsp. lactis R1058
131 mg (10 Billion CFU)
†
Top Medical Research Studies
9.5
Bifidobacterium lactis reduced diarrhea duration
Adjudicative efficacy of Bifidobacterium animalis subsp. lactis BLa80 in treating acute diarrhea in children: a randomized, double-blinded, placebo-controlled study.
Strong relevance due to significant findings
We explored the impact of Bifidobacterium animalis subsp. lactis BLa80 on diarrhea in young children through a well-structured, randomized, double-blinded, placebo-controlled study.
Our findings show that children receiving the probiotic experienced a significantly shorter duration of diarrhea and a higher recovery rate compared to those given a placebo.
Notably, we also observed beneficial changes in gut microbiome composition and gene functions that promote immune response.
This evidence suggests that Bifidobacterium lactis can effectively support recovery from acute diarrhea in children.
Our findings show that children receiving the probiotic experienced a significantly shorter duration of diarrhea and a higher recovery rate compared to those given a placebo.
Notably, we also observed beneficial changes in gut microbiome composition and gene functions that promote immune response.
This evidence suggests that Bifidobacterium lactis can effectively support recovery from acute diarrhea in children.
Read More
9.5
Lactococcus lactis shows immunization potential
A Lactococcus lactis-vectored oral vaccine induces protective immunity of mice against enterotoxigenic Escherichia coli lethal challenge.
Highly relevant to diarrhea research
We explored the effectiveness of a live recombinant Lactococcus lactis vaccine designed to combat enterotoxigenic Escherichia coli, a major cause of diarrhea. The study involved administering the vaccine to mice, who then showed strong immune responses, such as increased antibody production and T cell activation.
After being challenged with ETEC, these mice exhibited complete protection from the disease. This suggests that the Lactococcus lactis vaccine could be a promising oral vaccine candidate against E. coli-related diarrhea.
After being challenged with ETEC, these mice exhibited complete protection from the disease. This suggests that the Lactococcus lactis vaccine could be a promising oral vaccine candidate against E. coli-related diarrhea.
Read More
9
Bifidobacterium lactis helps reduce diarrhea
Adjunctive efficacy of Lactis XLTG11 for Acute diarrhea in children: A randomized, blinded, placebo-controlled study.
High relevance for children’s health
We evaluated the effectiveness of Bifidobacterium lactis XLTG11 in treating acute watery diarrhea in children through a rigorous randomized, double-blind, placebo-controlled trial.
Children who received the probiotic alongside their conventional treatment had significantly shorter diarrhea durations and hospital stays compared to those who only got standard care. Additionally, those taking Bifidobacterium showed better improvement rates and healthier gut microbiomes after treatment.
Overall, this study suggests that Bifidobacterium lactis can be a beneficial adjunct therapy for children suffering from diarrhea.
Children who received the probiotic alongside their conventional treatment had significantly shorter diarrhea durations and hospital stays compared to those who only got standard care. Additionally, those taking Bifidobacterium showed better improvement rates and healthier gut microbiomes after treatment.
Overall, this study suggests that Bifidobacterium lactis can be a beneficial adjunct therapy for children suffering from diarrhea.
Read More
Most Useful Reviews
9.5
Ease of stool passage
Perfect compatibility! I experienced plenty of gas the first week, but I now have regular bowel movements every morning. My mother, who suffers from irritable bowel syndrome, has also had success with this product. I have ordered more, as it has genuinely helped both me and my mother.
Read More
10
Feeling much better
Thank YOU! I had been feeling dreadful for months. Every time I ate, I experienced diarrhoea and constant stomach pain. After taking these for just one day, I feel significantly better. My stomach is no longer bloated, and I noticed a visible improvement in just one day. I'm so grateful I could cry. Thank you to everyone who posted reviews; they guided me to purchase these.
Read More
10
Perfect poops achieved
This product instantly stopped my lifetime of diarrhoea! I took 6 pills daily instead of the recommended 2, and it provided me with perfect stools. I had no more wet poops, which was a relief, and even helped a friend with constipation. This product genuinely balances bowel issues. I must order more as my symptoms have slowly returned.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 64 Researches
8
9.5
Probiotics improve H. pylori treatments
Efficacy of probiotics regimens for Helicobacter pylori eradication: A systematic review, pairwise, and network meta-analysis of randomized controlled trials.
Significant clinical implications noted.
We analyzed various studies on incorporating probiotics into treatments for Helicobacter pylori (H. pylori) infection. Our findings revealed that adding probiotics like Bifidobacterium longum improved the eradication rate significantly.
Specifically, we noted that the probiotic group experienced fewer side effects, including diarrhea, nausea, and abdominal pain. This suggests that probiotics could not only enhance the effectiveness of H. pylori treatment but also make it more comfortable for patients. Overall, these results support the use of probiotics in gastric therapies.
Specifically, we noted that the probiotic group experienced fewer side effects, including diarrhea, nausea, and abdominal pain. This suggests that probiotics could not only enhance the effectiveness of H. pylori treatment but also make it more comfortable for patients. Overall, these results support the use of probiotics in gastric therapies.
Read More
9.5
Bifidobacterium longum shows promise
A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live CECT 7347 (ES1) and heat-treated CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.
High relevance for IBS-D treatment
We conducted a randomized double-blind, placebo-controlled trial with 200 participants to see how well the probiotic CECT 7347 (ES1) and its heat-treated version (HT-ES1) could help those suffering from diarrhea-predominant irritable bowel syndrome (IBS-D). After 12 weeks of treatment, both ES1 and HT-ES1 showed significant improvements in symptom severity, with marked reductions in IBS-SSS scores compared to the placebo.
Secondary benefits included better stool consistency and quality of life, making these treatments promising options for managing IBS-D symptoms. These findings reflect meaningful advancements in probiotic and postbiotic solutions.
Secondary benefits included better stool consistency and quality of life, making these treatments promising options for managing IBS-D symptoms. These findings reflect meaningful advancements in probiotic and postbiotic solutions.
Read More
9.5
Bifidobacterium lactis reduced diarrhea duration
Adjudicative efficacy of Bifidobacterium animalis subsp. lactis BLa80 in treating acute diarrhea in children: a randomized, double-blinded, placebo-controlled study.
Strong relevance due to significant findings
We explored the impact of Bifidobacterium animalis subsp. lactis BLa80 on diarrhea in young children through a well-structured, randomized, double-blinded, placebo-controlled study.
Our findings show that children receiving the probiotic experienced a significantly shorter duration of diarrhea and a higher recovery rate compared to those given a placebo.
Notably, we also observed beneficial changes in gut microbiome composition and gene functions that promote immune response.
This evidence suggests that Bifidobacterium lactis can effectively support recovery from acute diarrhea in children.
Our findings show that children receiving the probiotic experienced a significantly shorter duration of diarrhea and a higher recovery rate compared to those given a placebo.
Notably, we also observed beneficial changes in gut microbiome composition and gene functions that promote immune response.
This evidence suggests that Bifidobacterium lactis can effectively support recovery from acute diarrhea in children.
Read More
9.5
Lactococcus lactis shows immunization potential
A Lactococcus lactis-vectored oral vaccine induces protective immunity of mice against enterotoxigenic Escherichia coli lethal challenge.
Highly relevant to diarrhea research
We explored the effectiveness of a live recombinant Lactococcus lactis vaccine designed to combat enterotoxigenic Escherichia coli, a major cause of diarrhea. The study involved administering the vaccine to mice, who then showed strong immune responses, such as increased antibody production and T cell activation.
After being challenged with ETEC, these mice exhibited complete protection from the disease. This suggests that the Lactococcus lactis vaccine could be a promising oral vaccine candidate against E. coli-related diarrhea.
After being challenged with ETEC, these mice exhibited complete protection from the disease. This suggests that the Lactococcus lactis vaccine could be a promising oral vaccine candidate against E. coli-related diarrhea.
Read More
9
LRa05 effective for diarrhea in children
LRa05 in the treatment of acute diarrhea in children: a randomized controlled trial.
High relevance due to significant findings
We examined the effectiveness of LRa05, a probiotic, in treating acute watery diarrhea in children. In a randomized controlled trial, 57 children received LRa05 while 54 received a placebo. Our findings showed that those who took LRa05 had shorter diarrhea durations and improved fecal consistency compared to the control group. Additionally, LRa05 improved gut microbiome composition and boosted levels of beneficial gut proteins. Overall, using LRa05 can be a helpful addition to managing diarrhea in young children.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 79 Reviews
7.8
10
Perfect poops achieved
This product instantly stopped my lifetime of diarrhoea! I took 6 pills daily instead of the recommended 2, and it provided me with perfect stools. I had no more wet poops, which was a relief, and even helped a friend with constipation. This product genuinely balances bowel issues. I must order more as my symptoms have slowly returned.
Read More
10
Chronic diarrhoea relief
Chronic diarrhoea is no longer an issue for me thanks to this product!
10
Digestive improvement
After a month of antibiotics, I developed severe constipation and diarrhoea. Nothing worked until I tried Jarro-Dophilus EPS, which restored my digestion within a week. I'm grateful for this product.
10
Miraculous improvement
For two months, I suffered from chronic diarrhoea due to irritable bowel syndrome. Traditional treatments failed, but this product was miraculous! I’ll continue buying it whenever I need relief.
10
Essential for children
Keeping probiotics at home is crucial, especially with a child. I have tried numerous brands and found these to be effective and budget-friendly. With eight unique strains, the 5 billion dosage suits my child well. Probiotics are necessary for managing both constipation and diarrhea, especially when a child falls ill. They are a staple for us, particularly during travel.
Read More
